Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

KRT14 antibody (AA 351-472) (CF®568)

This anti-KRT14 antibody is a Mouse Monoclonal antibody detecting KRT14 in IHC, FACS and IHC (fp). Suitable for Human, Rat, Mouse and Pig.
Catalog No. ABIN7655919

Quick Overview for KRT14 antibody (AA 351-472) (CF®568) (ABIN7655919)

Target

See all KRT14 Antibodies
KRT14 (Keratin 14 (KRT14))

Reactivity

  • 116
  • 74
  • 60
  • 15
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Human, Rat, Mouse, Pig

Host

  • 73
  • 49
  • 2
Mouse

Clonality

  • 63
  • 60
  • 1
Monoclonal

Conjugate

  • 72
  • 7
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This KRT14 antibody is conjugated to CF®568

Application

  • 51
  • 50
  • 40
  • 31
  • 26
  • 17
  • 15
  • 13
  • 13
  • 12
  • 11
  • 11
  • 10
  • 2
  • 2
  • 1
  • 1
Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Paraffin-embedded Sections) (IHC (fp))

Clone

KRT14-2375
  • Binding Specificity

    • 27
    • 15
    • 13
    • 9
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 351-472

    Purpose

    Cytokeratin 14 (KRT14) (Squamous Cell Marker)(KRT14/2375), CF568 conjugate

    Characteristics

    Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Immunogen

    Recombinant human KRT14 fragment (around aa351-472)

    Isotype

    IgG2a, kappa
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Comment

    Positive Control: A431 or HeLa cells. Skin or Squamous Cell Carcinoma.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.1 mg/mL

    Buffer

    PBS, 0.1 % BSA, 0.05 % azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Protect from light

    Storage

    4 °C

    Storage Comment

    Stable at room temperature or 37°C for 7 days.

    Protect from light

    Store at 2 to 8°C. Protect fluorescent conjugates from light

    Expiry Date

    24 months
  • Target

    KRT14 (Keratin 14 (KRT14))

    Alternative Name

    Keratin 14

    Background

    Synonyms: CK-14, Dowling Meara, ebs3, ebs4, Epidermolysis Bullosa Simplex, k14, Keratin 14, Keratin Type I Cytoskeletal 14, Koebner, krt14, NFJ

    Gene Symbol: KRT14

    Tissue Expression: Epithelial cells

    Molecular Weight

    ~50 kDa

    Gene ID

    3861

    UniProt

    P02533
You are here:
Chat with us!